Integra LifeSciences | IART - سود ناخالص در فروش

قیمت سهام
10.57
تغییر روزانه
0.25 2.42%
ماهیانه
10.68%
سالیانه
-37.12%
Q2 پیش بینی
10.34




سود ناخالص در فروش تغییر دادن تاریخ
Abbott USD 5.86B 675M 2026-03
AtriCure USD 105.34M 4M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.61B 64M 2026-03
CONMED USD 218.29M 52.17M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 535.95M 49.28M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Orthofix International USD 153.28M 4.76M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12